SNDL — SNDL Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for SNDL, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	40-F	40-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	60.9	56.1	712	909	920
Cost of Revenue
Gross Profit	9.18	5.52	154	190	240
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	250	221	1,078	1,076	1,023
Operating Profit	-189	-165	-366	-167	-102
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-206	-235	-380	-172	-106
Provision for Income Taxes
Net Income After Taxes	-206	-227	-372	-172	-96.2
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-233	-227	-335	-173	-94.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-233	-227	-335	-173	-94.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.811	-0.912	-0.878	-0.345	-0.313